Shares of Aquestive Therapeutics Inc. (AQST) are up over 11% at $4.74 in premarket trading today, as the company gears up for reporting financial results for the fourth quarter ended December 31, 2023, tomorrow.
The company has five commercialized products marketed by its licensees in the U.S. and around the world.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com